Cutaneous leishmaniasis (CL) is a vector-borne disease caused by obligate protist parasites from the genus Leishmania. The potential toxicity as well as the increased resistance of standard treatments has encouraged the development of new therapeutical strategies. Photodynamic inactivation (PDI) combines the use of a photosensitizer and light to generate reactive oxygen species and kill cells, including microorganisms. Vegetal kingdom constitutes an important source of bioactive compounds that deserve to be investigated in the search of naturally occurring drugs with leishmanicidal activity. The purpose of this study was to test the antiparasitic activity of PDI (ApPDI) of five natural anthraquinones (AQs) obtained from Heterophyllaea lycio...
Texto completo: acesso restrito. p. 850–855Background and Objective: Cutaneous and mucocutaneous lei...
Objectives. To evaluate the in vitro leishmanicidal activity of nine flavonoid derivatives from Delp...
Fil: Montanari, Jorge. Programa de Nanomedicinas, Departamento de Ciencia y Tecnología, Universidad ...
Cutaneous leishmaniasis (CL) is a neglected disease that promotes destructive lesions. Difficulties ...
Cutaneous and mucocutaneous leishmaniasis are diseases characterized by skin or mucosal manifestatio...
Cutaneous leishmaniasis (CL) is a zoonotic disease developed by protozoa parasites of genus Leishman...
Introduction: Cutaneous leishmaniasis (CL) is a widespread disease that is epidemic in Iran, too. Ph...
Introdução: A leishmaniose pode se apresentar sobre diferentes formas clínicas e causadas por difere...
Introduction: The treatment of cutaneous leishmaniasis (CL) is based primarily on the use of pentava...
A terapia fotodinâmica (PDT) é uma modalidade terapêutica utilizada para causar morte celular basead...
Introduction. Photodynamic therapy is a two-step procedure, involving the use ofphotosensitizing age...
Leishmaniasis is a zoonotic disease, regarded by WHO as a public health problem that has presented a...
Leishmaniose é uma zoonose desenvolvida por protozoários do gênero Leishmania. A doença se manifesta...
Light is known to excite photosensitizers (PS) to produce cytotoxic reactive oxygen species (ROS) in...
Introduction: Photodynamic therapy (PDT) using 5-aminolevulinic acid-induced protoporphyrin IX (ALA-...
Texto completo: acesso restrito. p. 850–855Background and Objective: Cutaneous and mucocutaneous lei...
Objectives. To evaluate the in vitro leishmanicidal activity of nine flavonoid derivatives from Delp...
Fil: Montanari, Jorge. Programa de Nanomedicinas, Departamento de Ciencia y Tecnología, Universidad ...
Cutaneous leishmaniasis (CL) is a neglected disease that promotes destructive lesions. Difficulties ...
Cutaneous and mucocutaneous leishmaniasis are diseases characterized by skin or mucosal manifestatio...
Cutaneous leishmaniasis (CL) is a zoonotic disease developed by protozoa parasites of genus Leishman...
Introduction: Cutaneous leishmaniasis (CL) is a widespread disease that is epidemic in Iran, too. Ph...
Introdução: A leishmaniose pode se apresentar sobre diferentes formas clínicas e causadas por difere...
Introduction: The treatment of cutaneous leishmaniasis (CL) is based primarily on the use of pentava...
A terapia fotodinâmica (PDT) é uma modalidade terapêutica utilizada para causar morte celular basead...
Introduction. Photodynamic therapy is a two-step procedure, involving the use ofphotosensitizing age...
Leishmaniasis is a zoonotic disease, regarded by WHO as a public health problem that has presented a...
Leishmaniose é uma zoonose desenvolvida por protozoários do gênero Leishmania. A doença se manifesta...
Light is known to excite photosensitizers (PS) to produce cytotoxic reactive oxygen species (ROS) in...
Introduction: Photodynamic therapy (PDT) using 5-aminolevulinic acid-induced protoporphyrin IX (ALA-...
Texto completo: acesso restrito. p. 850–855Background and Objective: Cutaneous and mucocutaneous lei...
Objectives. To evaluate the in vitro leishmanicidal activity of nine flavonoid derivatives from Delp...
Fil: Montanari, Jorge. Programa de Nanomedicinas, Departamento de Ciencia y Tecnología, Universidad ...